Abstract
BackgroundPlatinum resistance is a major challenge in the clinical treatment of advanced ovarian cancer (OC). Accumulating evidence shows that the tumor-promotive M2 macrophage is linked to the limiting chemotherapy efficacy...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have